Lazard Asset Management’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-550
Closed 2493
2024
Q4
$0 Hold
550
﹤0.01% 2457
2024
Q3
$0 Sell
550
-1,791
-77% -$2.46K ﹤0.01% 2396
2024
Q2
$2K Sell
2,341
-40,678
-95% -$63.4K ﹤0.01% 2105
2024
Q1
$69K Sell
43,019
-23,743
-36% -$19.9K ﹤0.01% 1650
2023
Q4
$37K Buy
66,762
+2,416
+4% +$968 ﹤0.01% 1973
2023
Q3
$25K Buy
64,346
+2,914
+5% +$1.44K ﹤0.01% 2069
2023
Q2
$32K Buy
61,432
+33,991
+124% +$21.8K ﹤0.01% 1969
2023
Q1
$22K Buy
27,441
+18,470
+206% +$20.1K ﹤0.01% 2037
2022
Q4
$11K Buy
+8,971
New +$14K ﹤0.01% 2192

Other funds holding OCGN

Lazard Asset Management's OCGN Position: Q1 2025 in Review

Lazard Asset Management sold out of Ocugen (OCGN) in Q1 2025, closing a stake of 550 shares.

Lazard Asset Management first reported a position in OCGN in Q4 2022 and held it in 9 quarters. The position peaked at $69K in Q1 2024. 110 funds tracked by Wall St. Rank hold OCGN as of Q1 2025.

  • Lazard Asset Management reported no remaining Ocugen position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 550 Ocugen shares in Q1 2025.
  • Lazard Asset Management first reported a position in Ocugen in Q4 2022 and held it in 9 quarters.
  • Lazard Asset Management's Ocugen position peaked at $69K in Q1 2024.
  • 110 funds tracked by Wall St. Rank held Ocugen as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.